MyAverix Finance
US · Healthcare
Avadel Pharmaceuticals PLC (AVDL)
Drug Manufacturers - Specialty & Generic
Avadel Pharmaceuticals PLC (AVDL) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for AVDL
Avadel Pharmaceuticals PLC (AVDL) — FAQ
What is AVDL's P/E ratio?
The price-to-earnings (P/E) ratio for Avadel Pharmaceuticals PLC (AVDL) is 18.00 (data as of 2026-03-23).
Does Avadel Pharmaceuticals PLC pay a dividend?
Dividend yield is not available in the current snapshot for Avadel Pharmaceuticals PLC (AVDL). Check the MyAverix Finance app for the latest dividend data.
What sector is Avadel Pharmaceuticals PLC in?
Avadel Pharmaceuticals PLC (AVDL) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is AVDL listed on?
AVDL is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.